Table 1 Demographic, clinical, laboratory, and cardiovascular disease-related characteristics in patients with axial spondyloarthritis
Variable | axSpA (n = 510) |
|---|---|
Men/women, n | 360/150 |
Age (years), mean ± SD | 48.8 ± 12.4 |
Age at axSpA diagnosis (years), mean ± SD | 35.8 ± 11.4 |
C-reactive protein (mg/L), mean ± SD | 5.7 ± 9.8 |
Erythrocyte sedimentation rate (mm/1st hour), mean ± SD | 10.9 ± 16.2 |
Bath Ankylosing Spondylitis Disease Activity Index, mean ± SD | 3.7 ± 2.3 |
Ankylosing Spondylitis Disease Activity Score, mean ± SD | 2.2 ± 1.0 |
Bath Ankylosing Spondylitis Functional Index, mean ± SD | 3.4 ± 2.6 |
HLA-B27 status, % | 78.0 |
Peripheral synovitis, % | 37.7 |
Hip involvement, % | 20.4 |
Enthesitis, % | 29.2 |
Extra-articular manifestations*, % | 36.5 |
Syndesmophytes, % | 43.5 |
History of classic cardiovascular risk factors, % | |
Smoking | 52.0 |
Obesity | 22.4 |
Dyslipidemia | 32.0 |
Hypertension | 26.6 |
Body mass index (kg/m2), mean ± SD | 27.2 ± 5.0 |
Systolic blood pressure (mm Hg), mean ± SD | 129.1 ± 17.6 |
Diastolic blood pressure (mm Hg), mean ± SD | 80.3 ± 11.2 |
Total cholesterol (mg/dL), mean ± SD | 191.2 ± 39.4 |
HDL-cholesterol (mg/dL), mean ± SD | 54.2 ± 16.5 |
LDL-cholesterol (mg/dL), mean ± SD | 115.4 ± 32.6 |
Triglycerides (mg/dL), mean ± SD | 122.7 ± 79.2 |
Atherogenic index (total cholesterol/HDL), mean ± SD | 3.8 ± 1.2 |
Atherogenic index ≥4, % | 36.5 |
Carotid IMT (mm), mean ± SD | 0.646 ± 0.144 |
Carotid plaques, % | 28.8 |